[ad_1]
DUBLIN, July 7, 2022 /PRNewswire/ — The “Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization” report has been added to ResearchAndMarkets.com’s offering.
Key Topics Covered:
1 Molecular Dx Oncology Market – Strategic Situation Analysis with Impact of the COVID-19 Pandemic
2 Guide for Executives, Marketing, Sales and Business Development Staff
3 Guide for Management Consultants and Investment Advisors
4 Introduction and Market Definition
5 Market Overview
5.1 Market Participants
5.1.1 Academic Research Lab
5.1.2 Diagnostic Test Developer
5.1.3 Genomic Instrumentation Supplier
5.1.4 Cell Separation and Viewing Instrumentation Supplier.
5.1.5 Pharmaceutical/Reagent Supplier
5.1.6 Independent Testing Lab
5.1.7 Public National/Regional Lab
5.1.8 Hospital lab
5.1.9 Physician Lab
5.1.10 Audit Bodies
5.1.11 Certification Body
5.2 Market Segments
5.2.1 Traditional Market Segmentation
5.2.2 Laboratory Focus and Segmentation
5.3 Industry Structure
5.3.1 Hospital Testing Share
5.3.2 Economies of Scale
5.3.3 Physician Office Labs
5.3.4 Physicians and POCTs
6 Market Trends
6.1 Factors Driving Growth
6.1.1 New Diagnostics Create New Markets
6.1.2 New Roles for Diagnostics
6.1.3 Longevity and Outcomes
6.1.4 Expanding the Pharmaceutical Toolbox
6.1.5 Regulatory Retreat
6.2 Factors Limiting Growth
6.2.1 Falling Prices
Full story available on Benzinga.com
[ad_2]
Source link
